PDX Portal

Pancreas Collection

Filter Data:

Patients (25)

PDX (25)

Collection Summaries:

Collection Details:

Search All Columns:

Model IDFilter by Model ID	Patient IDFilter by Patient ID	Pathology Diagnosis Select Adenocarcinoma (pancreatobiliary) High grade Adenocarcinoma Pancreatic ductal adenocarcinoma	Patient Biomarkers			NCCN Stage Select Resectable Borderline Metastatic	BMI Select <20 20-25 25-30 30-35 >35	Survival in MonthsFilter by Survival in Months	Age at Diagnosis Select 41-50 51-60 61-70 >70	Race Select Asian Black or African American Hispanic or Latino White White,Hispanic or Latino	Gender Select Female Male	Grade Select G2 G2.5 G3 G4 Not Reported	Stage Select IB IIA IIB III IV	Patient TreatmentFilter by Patient Treatment
Model IDFilter by Model ID	Patient IDFilter by Patient ID		CA 19-9Filter by CA 19-9	BilirubinFilter by Bilirubin	Risk FactorFilter by Risk Factor	NCCN Stage Select Resectable Borderline Metastatic	BMI Select <20 20-25 25-30 30-35 >35	Survival in MonthsFilter by Survival in Months	Age at Diagnosis Select 41-50 51-60 61-70 >70		Gender Select Female Male	Grade Select G2 G2.5 G3 G4 Not Reported	Stage Select IB IIA IIB III IV	Patient TreatmentFilter by Patient Treatment
BCM-PAN-11	3429743	Pancreatic ductal adenocarcinoma	23.5	0.6			24.0	12	40.89	White	Male	G2	IIB	Folfox,Gemcitabine
BCM-PAN-3	5126872	Pancreatic ductal adenocarcinoma	5	0.8	Pancreatitis	Resectable	26.6	25	55.19	Black or African American	Male	G3	IIA
BCM-PAN-5	3333427	Pancreatic ductal adenocarcinoma	25.8	8.6		Resectable	23.0	15	69.9	White,Hispanic or Latino	Female	G2	IIB	Fluorouracil,Gemcitabine
BCM-PDAC-1	4622397	Pancreatic ductal adenocarcinoma	79.2	3.5	Tobacco	Borderline	21.3	55	58.43	White	Male	G2	IIB	Abraxane,Capecitabine,Gemcitabine
BCM-PDAC-10	5695792	Pancreatic ductal adenocarcinoma	79	0.8	Tobacco, Pancreatitis	Resectable	21.0	27	58.14	White	Female	G2	IIB	Folfirinox
BCM-PDAC-11	6046120	High grade Adenocarcinoma			Tobacco, Pancreatitis	Resectable	23.75	23	59.9	White	Male	G3	IIB	Abraxane,Capecitabine,Folfirinox,Folfox,Gemcitabine
BCM-PDAC-13	6125394	Pancreatic ductal adenocarcinoma	106	0.2	Diabetes, Tobacco, Pancreatitis	Resectable	22.5	14	64.75	Hispanic or Latino	Male	G3	IIB	Abraxane,Gemcitabine
BCM-PDAC-14	6142831	Pancreatic ductal adenocarcinoma	401.2	0.5	Diabetes	Resectable	40.05	12	64.32	White	Female	G2	IIB	Gemcitabine
BCM-PDAC-18	6652135	Pancreatic ductal adenocarcinoma			Diabetes	Resectable	30.75	42	65.02	White	Male	G2	IIB	Abraxane,Capecitabine,Gemcitabine
BCM-PDAC-19	6714659	Pancreatic ductal adenocarcinoma	2600	2.4	Tobacco, Diabetes	Resectable	29.3	17	71.97	White	Female	G2	IIB	Gemcitabine
BCM-PDAC-2	4639492	Pancreatic ductal adenocarcinoma	192.2	0.6	Tobacco	Resectable	22.24	15	88.58	White	Male	G2	IIB
BCM-PDAC-25	8471998	Pancreatic ductal adenocarcinoma	988	16.5		Resectable	39.0	6	66.13	White	Male	G3	IIB	folfirinox
BCM-PDAC-26	8635396	Pancreatic ductal adenocarcinoma	186	0.6		Resectable	22.06	15	46.68	Black or African American	Female	G2	IIB	Gemcitabine,capecitabine
BCM-PDAC-28	8944795	Adenocarcinoma (pancreatobiliary)			Tobacco	Resectable	28.11	21	59.08	White	Male	G2.5	IV	Abraxane with investigational agent (HALO 301),Gemcitabine
BCM-PDAC-29	8988670	Pancreatic ductal adenocarcinoma	534	0.3	Diabetes, Tobacco, Pancreatitis	Resectable	47.01	28	65.43	Black or African American	Female	G2	IIA	Abraxane,Capecitabine,Gemcitabine,capecitabine

* indicates the model is private.

Select Search Parameters:

Collection Site:

Permission:

Public and Private

Public Only

Private Only

Gene(s):*

Select Genes Individually

Copy/Paste Gene List

Find By

Please contact us for gene list greater than 100.

Plot Type:

Intensity Plot

Type Plot

SITE LINKS

Contact Us
Portal Team
Log In
Baylor College of Medicine
Advanced In Vivo Models Unit

COLLECTIONS

Bladder
Breast
Leukemia
Pancreas
Pediatric Liver
Sarcoma

CONTACT

PDX Development Unit
Advanced In Vivo Models Unit
PDX Pediatric Liver Program

© 2021 Biomedical Informatics Group, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine